Personal information

Other IDs

ResearcherID: M-5710-2014

Keywords

biomedicine, biology

Countries

Spain

Activities

Collapse all

Education and qualifications (3)

Universidad Autónoma de Madrid: Madrid, Madrid, ES

2013-06-01 to 2017-05-16 | Molecular Bioscience PhD (Departamento de Bioquímica)
Education
Source: Self-asserted source
Alba Mota Jimenez

Universidad Autonoma de Madrid Facultad de Medicina: Madrid, ES

2012-06 | Molecular Biomedicine Master
Education
Source: Self-asserted source
Alba Mota Jimenez

Universidad Autonoma de Madrid Facultad de Ciencias: Madrid, ES

2011-06 | Master in Biochemistry Degree (Sciences Faculty)
Education
Source: Self-asserted source
Alba Mota Jimenez

Works (11)

Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

Modern Pathology
2017-01 | Journal article
DOI: 10.1038/modpathol.2016.143
Contributors: Alba Mota; Eva Colás; Pablo García-Sanz; Irene Campoy; Alejandro Rojo-Sebastián; Sonia Gatius; Ángel García; Luis Chiva; Sonsoles Alonso; Antonio Gil-Moreno et al.
Source: check_circle
Crossref

Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma: A Pharmacodynamic Phase II Study

Int J Gynecol Cancer
2016 | Journal article
DOI: 10.1097/IGC.0000000000000715
Contributors: Santacana, M.; Coronado, P.; Matias-Guiu, X.; Romero, I.; Casado, A.; Gil-Moreno, A.; Dosil, M. A.; Mota, A.; Moreno-Bueno, G.; Dolcet, X. et al.
Source: Self-asserted source
Alba Mota Jimenez via ResearcherID

Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

Oncotarget
2016 | Journal article
DOI: 10.18632/oncotarget.10787
Contributors: Hergueta-Redondo, M.; Sarrio, D.; Molina-Crespo, Á; Vicario, R.; Bernadó-Morales, C.; Martínez, L.; Rojo-Sebastián, A.; Serra-Musach, J.; Mota, A.; Martínez-Ramírez, Á et al.
Source: Self-asserted source
Alba Mota Jimenez via ResearcherID

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies

EBioMedicine
2016 | Journal article
DOI: 10.1016/j.ebiom.2016.06.048
Contributors: Hellner, K.; Miranda, F.; Fotso Chedom, D.; Herrero-Gonzalez, S.; Hayden, D. M.; Tearle, R.; Artibani, M.; KaramiNejadRanjbar, M.; Williams, R.; Gaitskell, K. et al.
Source: Self-asserted source
Alba Mota Jimenez via ResearcherID

A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2015 | Journal article
DOI: 10.1038/modpathol.2015.102
WOSUID:

MEDLINE:26381823
Contributors: Romero-Perez, Laura; Garcia-Sanz, Pablo; Mota, Alba; Leskela, Susanna; Hergueta-Redondo, Marta; Diaz-Martin, Juan; Lopez-Garcia, M. Angeles; Castilla, M. Angeles; Martinez-Ramirez, Angel; Soslow, Robert A. et al.
Source: Self-asserted source
Alba Mota Jimenez via ResearcherID

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression

BMC cancer
2015 | Journal article
DOI: 10.1186/s12885-015-1952-z
WOSUID:

MEDLINE:26620706
Contributors: Mota, Alba; Trivino, Juan Carlos; Rojo-Sebastian, Alejandro; Martinez-Ramirez, Angel; Chiva, Luis; Gonzalez-Martin, Antonio; Garcia, Juan F.; Garcia-Sanz, Pablo; Moreno-Bueno, Gema
Source: Self-asserted source
Alba Mota Jimenez via ResearcherID

α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation

Toxicology and Applied Pharmacology
2015-08 | Journal article
DOI: 10.1016/j.taap.2015.04.012
Contributors: Alba Mota; Lidia Jiménez-Garcia; Sandra Herránz; Beatriz de las Heras; Sonsoles Hortelano
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

Human Pathology
2014 | Journal article
DOI: 10.1016/j.humpath.2014.06.031
WOSUID:

WOS:000345954100004
Contributors: Santacana, M.; Maiques, O.; Valls, J.; Gatius, S.; Abo, A. I.; Lopez-Garcia, M. A.; Mota, A.; Reventos, J.; Moreno-Bueno, G.; Palacios, J. et al.
Source: Self-asserted source
Alba Mota Jimenez via ResearcherID

Gasdermin-B promotes invasion and metastasis in breast cancer cells.

2014 | Journal article
DOI:

10.1371/journal.pone.0090099

PMID:

24675552

PMC:

PMC3967990
Contributors: Hergueta-Redondo M; Sarrió D; Molina-Crespo Á; Megias D; Mota A; Rojo-Sebastian A; García-Sanz P; Morales S; Abril S; Cano A et al.
Source: Self-asserted source
Alba Mota Jimenez via Europe PubMed Central
grade
Preferred source (of 2)‎

A SILAC approach to MT1-MMP degradome in inflammatory angiogenesis

Vascular Pharmacology
2012 | Journal article
DOI: 10.1016/j.vph.2011.08.207
WOSUID:

WOS:000306889400219
Contributors: Martinez-Koziol, Agnieszka; Gonzalo, Pilar; Pollan, Angela; Mota, Alba; Colome, Nuria; Montaner, David; Dopazo, Joaquin; Arribas, Joaquin; Canals, Francesc; Arroyo, Alicia G.
Source: Self-asserted source
Alba Mota Jimenez via ResearcherID

The protease MT1-MMP drives a combinatorial proteolytic program in activated endothelial cells.

2012-11 | Journal article
DOI:

10.1096/fj.12-205906

PMID:

22859368
Contributors: Koziol A; Gonzalo P; Mota A; Pollán Á; Lorenzo C; Colomé N; Montaner D; Dopazo J; Arribas J; Canals F et al.
Source: Self-asserted source
Alba Mota Jimenez via Europe PubMed Central
grade
Preferred source (of 2)‎
How many people are using ORCID?